Idiopathic pulmonary fibrosis and drugs of ingredients of mebeverine hydrochloride - a phase IV clinical study of FDA data
Idiopathic pulmonary fibrosis is found among people who take drugs with ingredients of mebeverine hydrochloride, especially for people who are female, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 3,759 people who have side effects when taking drugs with ingredients of mebeverine hydrochloride from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Colofac, Duspatal, Duspatalin, Mebeverine hydrochloride.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,759 people reported to have side effects when taking drugs with ingredients of mebeverine hydrochloride.
Among them, 11 people (0.29%) have Idiopathic pulmonary fibrosis
What is Idiopathic pulmonary fibrosis?
Idiopathic pulmonary fibrosis (chronic lung disease) is found to be associated with 2,462 drugs and 2,146 conditions by eHealthMe.
Number of reports submitted per year:
Gender of people who have Idiopathic pulmonary fibrosis when taking drugs with ingredients of mebeverine hydrochloride *:
- female: 63.64 %
- male: 36.36 %
Age of people who have Idiopathic pulmonary fibrosis when taking drugs with ingredients of mebeverine hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Conditions people have *:
- Hepatitis C: 3 people, 27.27%
- Poor Quality Sleep: 1 person, 9.09%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 9.09%
Other drugs people take *:
- Warfarin Sodium: 3 people, 27.27%
- Pegasys: 3 people, 27.27%
- Digoxin: 3 people, 27.27%
- Rebetol: 3 people, 27.27%
- Prednisolone: 3 people, 27.27%
- Fluoxetine: 3 people, 27.27%
- Amlodipine: 2 people, 18.18%
- Prazepam: 2 people, 18.18%
- Rituxan: 2 people, 18.18%
- Paracetamol: 1 person, 9.09%
Other side effects people have besides Idiopathic pulmonary fibrosis *:
- Common Peroneal Nerve Dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes): 3 people, 27.27%
- Insomnia (sleeplessness): 2 people, 18.18%
- Pneumonia: 2 people, 18.18%
- Cough: 2 people, 18.18%
- Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 2 people, 18.18%
- Impaired Work Ability: 1 person, 9.09%
- Breathing Difficulty: 1 person, 9.09%
- Fatigue (feeling of tiredness): 1 person, 9.09%
- Fever: 1 person, 9.09%
- Hyperhidrosis (abnormally increased sweating): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of mebeverine hydrochloride, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on mebeverine hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Osteopenia and Bursitis - now
- Depo-Provera and Cutaneous Lupus Erythematosus - 5 seconds ago
- Diazepam and Aggression - 5 seconds ago
- Definity and Contrast Media Reaction - 5 seconds ago
- Zolmitriptan and Cimzia drug interaction - 5 seconds ago
- Depo-Provera and Thyroiditis - 6 seconds ago
- Dilaudid and Hypertensive Encephalopathy - 7 seconds ago
- Dacogen and Depression - 8 seconds ago
- Depakene and Epilepsy - 9 seconds ago
- Depo-Medrol and Appendix Disorder - 10 seconds ago